Giuliani L, Pescatore D, Martorana G, Giberti C, Barreca T, Rolandi E
Br J Urol. 1979 Oct;51(5):390-2. doi: 10.1111/j.1464-410x.1979.tb02892.x.
Prolactin (PRL) pituitary reserve was measured in 8 patients with prostatic adenoma and 11 patients with prostatic carcinoma. The PRL reserve was significantly higher in these patients compared to an age-matched control group of 6 subjects. A possible role for PRL-inhibiting drugs in the management of oestrogen-resistant carcinomas of the prostate is suggested.
对8例前列腺腺瘤患者和11例前列腺癌患者进行了催乳素（PRL）垂体储备功能检测。与6名年龄匹配的对照组受试者相比，这些患者的PRL储备显著更高。提示PRL抑制药物在前列腺雌激素抵抗性癌的治疗中可能发挥作用。
